Company Active LTD

Company profile

Iontas Limited

Home - IONTAS

Iontas Limited is a UK company with status active founded in 2009.

CRN
06785483
Founded
2009
Age
17

Overview

Legal name
IONTAS LIMITED
Region
Unknown
Registered address
C/O CSC CLS (UK) LIMITED 5 CHURCHILL PLACE
10TH FLOOR
LONDON
UNITED KINGDOM
E14 5HU
Insolvency history
No

Corporate ownership

Updated 06 Jun 2026 16:52

8 levels 2 ultimate controllers
1
Company Active LTD
Iontas Limited
CRN 06785483
2
Direct controller Active LTD
Alegre Interco Limited
CRN 12403483
3
Intermediate controller Active LTD
4
Intermediate controller Active LTD
5
Intermediate controller Active LTD
Llama Bidco Limited
CRN 15786333
6
Intermediate controller Active LTD
Llama Midco Limited
CRN 15785979
7
Intermediate controller Active LTD
Llama Holdco Limited
CRN 15851689
8
Intermediate controller Active LIMITED-PARTNERSHIP
9
Ultimate controller
CHE-108.562.489
CRN CHE-108.562.489
10
Ultimate controller Active LLP

Company events

Reference milestones and recent Companies House filing stream events.

17 events
30 Sep
2026

Accounts due

Accounts Due

Next accounts due date

26 May
2026

Change Person Director Company With Change Date

Officers

CH01 | Transaction MzUyMzY3OTk2NWFkaXF6a2N4

Published 26 May 2026 13:09

29 Jan
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

15 Jan
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Dec
2024

Accounts filed

Accounts

Last accounts made up date

25 Sep
2024

Accounts With Accounts Type Full

Accounts PDF pending

AA | Transaction MzQzNjgwOTcyOGFkaXF6a2N4 | Paper/PDF filed

Published 26 Sep 2024 06:25

21 Sep
2024

Memorandum Articles

Incorporation

MA | Transaction MzQzNjAzNTU5OWFkaXF6a2N4 | Paper/PDF filed

Published 24 Sep 2024 06:48

21 Sep
2024

Resolution

Resolution

RESOLUTIONS | Transaction WURCUzVIR0lhZGlxemtjeA | Paper/PDF filed

Published 22 Sep 2024 05:50

18 Sep
2024

Appoint Person Director Company With Name Date

Officers

AP01 | Transaction MzQzNjQwNjM2M2FkaXF6a2N4

Published 18 Sep 2024 15:22

16 Sep
2024

Appoint Corporate Secretary Company With Name Date

Officers

AP04 | Transaction MzQzNjAzNDYzMGFkaXF6a2N4

Published 16 Sep 2024 17:55

16 Sep
2024

Termination Director Company With Name Termination Date

Officers

TM01 | Transaction MzQzNjAzNDU1NGFkaXF6a2N4

Published 16 Sep 2024 17:52

16 Sep
2024

Termination Secretary Company With Name Termination Date

Officers

TM02 | Transaction MzQzNjAzNDUwNGFkaXF6a2N4

Published 16 Sep 2024 17:50

16 Sep
2024

Change Registered Office Address Company With Date Old Address New Address

Address

AD01 | Transaction MzQzNjAzNDQ4OGFkaXF6a2N4

Published 16 Sep 2024 17:49

16 Sep
2024

Appoint Person Director Company With Name Date

Officers

AP01 | Transaction MzQzNjAzNDEwNWFkaXF6a2N4

Published 16 Sep 2024 17:35

23 Aug
2024

Change To A Person With Significant Control

Persons-with-significant-control

PSC05 | Transaction MzQzMzI2NDE0MGFkaXF6a2N4

Published 23 Aug 2024 15:46

23 Aug
2024

Change To A Person With Significant Control

Persons-with-significant-control

PSC05 | Transaction MzQzMzI2MzYwMWFkaXF6a2N4

Published 23 Aug 2024 15:40

07 Jan
2009

Incorporated

Inception

Company registered at Companies House

Public funding

2 awards
First funded
2016
Funded years
2016, 2018
Age at first award
7 years

Projects

2018 Feasibility Studies Lead participant

Creating novel Nav1.7 inhibiting antibodies for the treatment of chronic pain

1 Jul 2018 to 30 Apr 2020

Awarded
£543,363
Total cost £776,233

"One in three adults will experience chronic pain (persistent pain lasting more than three months). Effective treatment for often highly debilitating chronic pain is limited and problematic: the most commonly prescribed medications are opioids (e.g. codeine, fentanyl, morphine) which have serious side-effects**.** To address the lack of safe, non-addictiv...

2016 EU-Funded Lead participant

CovlsoLink

1 Sep 2016 to 31 Aug 2018

Awarded
£174,595
Total cost £290,990

Awaiting Public Project Summary

Product types

EU-Funded Feasibility Studies